Recommend Cell Cycle to your librarian for 2008. Download form here.

Sign up for Table of Contents Alerts.

home subscribe search archive forthcoming

Email this page Print this page

Report

Differential Repression of c-myc and cdc2 Gene Expression by ERF and PE-1/METS

Kelly D. Hester, Dominique Verhelle, Laure Escoubet-Lozach, Rosa Luna, David W. Rose and Christopher K. Glass

volume 6 | issue 13

1 July 2007
Pages: 1594 - 1604

Purchase article for $19

Subscribe to this journal for $129/year

The molecular mechanisms that control the proliferation and differentiation of specific cell types remain poorly understood. Positive ETS factors play important roles in mediating proliferative responses to Ras/MAPK signaling in many cell types following mitogenic stimulation. PE-1/METS, a member of the ETS-domain family transcription factors that functions as a transcriptional repressor, can block mitogenic responses mediated by positively acting Ets factors. The anti-proliferative functions of PE-1/METS require its interaction with DP103, a multifunctional DEAD-box protein that mediates interactions with co-repressor proteins and acts in a cooperative manner with Rb family members and to repress cell cycle control genes. ETS-2 Repressor Factor (ERF) is structurally related to and also functions as a transcriptional repressor, but endogenous target genes and mechanisms of repression remain unknown. Here, we demonstrate that like PE-1/METS, ERF-mediated repression also requires DP103, and that ERF negatively regulates the c-myc and cdc2 genes. In contrast to PE-1/METS, however, ERF-mediated repression of these genes is inactivated by MAPK signaling through phosphorylation sites that are ERF-specific. Furthermore, constitutive activation of the Ras/MAPK pathway in RAW 264.7 cells transformed by the v-Abelson leukemia virus is associated with constitutive inactivation of ERF in this cell type. We propose that ERF and PE-1/METS function to impose ‘repression checkpoints’ on a subset of cell cycle control genes that are differentially regulated by growth factor signaling pathways that control proliferation and differentiation and that ERF is targeted for inactivation by transforming oncogenes such as vAbl.

Authors

Kelly D. Hester

University of California, San Diego; La Jolla, California

Dominique Verhelle

University of California, San Diego; La Jolla, California

Laure Escoubet-Lozach

University of California, San Diego; La Jolla, California

Rosa Luna

University of California, San Diego; La Jolla, California

David W. Rose

University of California, San Diego; La Jolla, California

Christopher K. Glass

University of California, San Diego; La Jolla, California


Purchase article for $19

Subscribe to this journal for $129/year